top of page

Transforming Screening at Austria's Leading Clinical Research Coordination Center (CRCC)

db648ac7-bf28-444c-aac7-b08f7b4c3cdb (1).png
40
per participant
min
reduction in screening time
77%
9
4 weeks
to first participants enrolled
after implementation
Full
screening adherence
01_overview.png
02_challenge.png

The Execution Layer

for Complex Protocols

Others help sites follow the protocol.

DragOnFlow compiles the protocol
into the workflow

The Execution Layer

for Complex Protocols

Others help sites follow the protocol.

DragOnFlow compiles the protocol
into the workflow

The Execution Layer

for Complex Protocols

Others help sites follow the protocol.

DragOnFlow compiles the protocol
into the workflow

The Execution Layer

for Complex Protocols

Others help sites follow the protocol.

Overview

 

A leading Clinical Research Coordination Center (CRCC) in Austria, supporting four medical centers and clinics, partnered with DragOnFlow to address one of the most critical bottlenecks in clinical trials: patient screening, selection, and enrollment.

03_solution.png
The Solution

 

CRCC implemented DragOnFlow’s protocol execution platform within their screening workflow. The platform transforms static protocols into interactive, step-by-step digital guides that:

 

  • Automate protocol adherence

  • Guide users in real time based on patient data

  • Eliminate the need for manual cross-referencing

  • Integrate seamlessly into existing workflows

04_results.png
The Results

 

Following implementation, CRCC conducted a direct comparison between traditional screening methods and DragOnFlow-enabled screening.

The impact was immediate and measurable:

 

  • 77% reduction in screening time (from 40 minutes to 9 minutes)

  • Improved accuracy through automated protocol adherence

  • Real-time decision support based on patient-specific data

  • Streamlined workflows with no need for multiple document checks

d870f76e-e805-4ea5-841a-a768677fe67a.png
05_impact.png
Impact

 

By replacing manual processes with guided digital execution, DragOnFlow enabled CRCC to improve both efficiency and quality, two critical factors in modern clinical research.

The Challenge

 

Participant screening is a complex and time-intensive process, requiring careful evaluation of eligibility criteria. This challenge is amplified in rare diseases such as myelofibrosis, where protocols are highly detailed and require significant expertise and precision.

Traditionally, screening involved extensive manual cross-referencing across multiple documents, which led to inefficiencies, delays, and increased risk of errors. Each screening could take up to 40 minutes, limiting throughput and slowing down trial progress.

bottom of page